Post

AstraZeneca champions early kidney disease diagnosis with modelling data

AstraZeneca has highlighted both the economic and environmental benefits of implementing early, targeted screening for chronic kidney disease (CKD). CKD is …

Tacalyx extends seed funding round to raise over €14m

Cancer-focused biotech Tacalyx has extended its seed financing round to raise over €14m ($15.03m). The German biotech has established a pipeline …

UK clinical trial sector must address prolonged timelines, say experts

Following a 2023 review of the UK clinical trial landscape, Lord James O’Shaughnessy, the former health minister highlighted major change …

J&J-backed Bright Peak secures $90m to advance immunoconjugate programme

Bright Peak Therapeutics has raised $90m in a Series C financing round as the biotech looks to make a name …

Amphastar Pharmaceuticals gets grant for medication container assembly with cap and hold down members

Amphastar Pharmaceuticals has patented a medication delivery system with a container assembly that prevents premature discharge during storage. The system …